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Abstract: The ability to accurately and non-invasively quantify highly concentrated magnetic
nanoparticles (MNPs) is desirable for many emerging applications. Ultrashort echo time quantitative
susceptibility mapping (UTE-QSM) has demonstrated the capability to detect high iron concentrations.
In this study, we aimed to investigate the effect of different sampling trajectories on the accuracy
of quantification based on MNPs acquired through UTE-QSM. A phantom with six different MNP
concentrations was prepared for UTE-QSM study with different UTE sampling trajectories, including
radial acquisition, continuous single point imaging (CSPI), and Cones with four different gradient
stretching factors of 1.0, 1.2, 1.4, and 1.6. No significant differences were found in QSM values
derived from the different UTE sampling strategies, suggesting that the UTE-QSM technique could
be accelerated with extended Cones sampling.
Keywords: magnetic resonance imaging; magnetic nanoparticles; quantitative susceptibility
mapping; ultrashort echo imaging
1. Introduction
In the past ten years, magnetic nanoparticles (MNPs) have been used in many medical branches,
such as cell labeling, drug delivery, magnetic resonance imaging (MRI), and magnetic hyperthermia
for cancer therapy [1,2]. Magnetic thermal therapy for cancer treatment kills cancer cells by increasing
the local temperature. Currently, there are two kinds of heating treatments: hyperthermia to stimulate
the immune response for non-specific immunotherapy (41–46 ◦C) [3] and thermo-ablation (46–56 ◦C)
to initiate cell necrosis/coagulation/carbonization for tumor destruction [4]. With this approach,
tumors can be destroyed with minimal harm to healthy tissues, thus reducing the negative side effects
associated with the delivery of drugs. In this way of cancer therapy, MNPs are injected directly into
the tumor; then, an external alternating magnetic field with a specific frequency between 50 kHz to
1.2 MHz is applied to heat the MNPs [5]. Accurate knowledge of the distribution of the MNPs within
the body is important for treatment planning [6]. The ability to accurately and non-invasively quantify
highly concentrated MNPs is closely related to the rapidly growing area of magnetic biosensing [7–9].
Magnetic resonance imaging (MRI), which is free from ionizing radiation and allows for rich contrast
mechanisms, is naturally suitable for imaging of the MNPs in vivo.
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Quantitative susceptibility mapping (QSM) has recently emerged as a promising technique in
MRI to quantitatively measure magnetic susceptibility using magnetic resonance phase images, which
can provide clinically important information such as iron deposition, calcification, demyelination, and
oxygenation [10–15]. QSM typically utilizes gradient recalled echo (GRE) imaging to obtain the phase
images. Therefore, QSM may allow for the detection of the MNPs distribution in the human body
with more specific physical meanings [16]. However, the MNPs concentration required for efficient
hyperthermia is generally greater than 18 mM (1 mg/mL) of iron [17]. Currently, conventional clinical
GRE sequences are unable to quantify the concentration of MNPs in the therapeutic range because
the MRI signal of iron above 9 mM—which is the upper limit of regular MRI techniques in assessing
highly concentrated MNPs [17]—is dominated by noise, even at the shortest possible echo times due
to its ultrashort T2* value.
Advanced techniques with much reduced echo time (TE), including ultrashort echo time (UTE)
imaging [18,19], zero echo time (ZTE) imaging [20], hybrid encoding [21,22], and sweep imaging with
Fourier transformation (SWIFT) [23], make it possible to accurately quantify highly concentrated MNPs
with MRI [17,24–26]. Our previous preliminary study showed that UTE-QSM with three-dimensional
(3D) Cones trajectories could increase the detection range of iron concentrations (up to 22 mM). Shorter
first echo time and shorter echo spacing were shown to be key factors contributing to increased
detection range [27]. Following that study, we successfully implemented 3D continuous single point
imaging (CSPI)-based UTE-QSM for the estimation of high iron concentrations [28]. Besides Cones
and CSPI, conventional radial or projection reconstruction (PR)-based UTE-QSM has also been used
for the evaluation of ultrashort T2* tissues, such as cortical bone [29].
In this study, we aimed to investigate the effect of different UTE sampling strategies on the
QSM-based evaluation of MNPs concentration. UTE images acquired at different TEs were used
together with a morphology-enabled dipole inversion (MEDI) algorithm to estimate QSM values [30].
A phantom with different iron concentrations ranging from 2 to 22 mM was built to systematically
compare three different UTE sampling strategies including PR, CSPI, and Cones. Moreover, different
gradient stretching factors in Cones imaging were also compared to investigate the effect of acceleration
on QSM quantification accuracy.
2. Materials and Methods
2.1. 3D Ultrashort Echo Time Imaging Schemes
In this study, three different UTE imaging schemes were compared in QSM estimation: 3D
UTE-CSPI, 3D UTE-PR, and 3D UTE-Cones sequences. Figure 1a shows a pulse sequence diagram
(PSD) for 3D UTE-CSPI, where gradients were switched on, rapidly ramped up with maximum
slew rate after RF excitation, ramped down, and switched off once the desired resolution (or spatial
frequency) was achieved. After switching off the gradients, data were continuously acquired at a
fixed k-space location, where myriad k-space was acquired with extremely high temporal resolution
(e.g., echo spacing of 2 µs) in a single scan. CSPI is based on pure phase encoding, where the readout
duration is nearly zero, which allows one to capture a true snapshot of the phase in transverse
magnetization. For more time-efficient encoding, CSPI can be performed with acceleration techniques
(e.g., parallel imaging or compressed sensing). In this study, generalized autocalibrating partially
parallel acquisitions (GRAPPA) was utilized to further accelerate CSPI [31]. Figure 1b shows a PSD for
3D UTE-PR imaging, which utilized a straight radial sampling trajectory. In the PR imaging, trapezoidal
gradients were applied to achieve fast encoding of the quickly decaying UTE signal. Figure 1c shows a
PSD for 3D UTE-Cones imaging, where a short rectangular pulse excitation was used, followed by
data readout with efficient Cones spiral trajectory with a minimal nominal TE of 32 µs (a minimal TE
of 8 µs could be achieved with the addition of a fast transmit/receive switch) [32–35]. The 3D k-space
was divided into multiple cones, with twisted spiral trajectories along each cone. The trajectory could
be made more or less twisted (i.e., longer or shorter spiral arms), which was associated with a relative
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stretching factor (SF). Typically, more gradient stretching meant a longer readout duration, which
reduced the scan time at the cost of shorter T2* blurring or a chemical shift artifact (intra-voxel signal
interference).
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Figure 1. Three different sequences for the comparative ultrashort echo time quantitative susceptibility
mapping (UTE-QSM) studies: (a) the 3D UTE continuous single point imaging (CSPI) sequence with a
minimum echo time (minTE) of 528 µs, (b) the 3D UTE projection reconstruction (PR) (radial) sequence
with a minimum TE of 32 µs, (c) the 3D UTE Cones sequence with a minimum TE of 32 µs. (RF means
Radio Frequency pulse, DAW means Data Acquisition Window).
2.2. Iron Phantom Design
An iron phantom was prepared with six tubes, each filled with 2 mL of six different concentrations
of Feridex I.V.® solution (Berlex Laboratories, Wayne, NJ, USA). Feri ex I.V.® (ferum xides injectable
solution) is a sterile aqueous colloid of superparamagnetic iron oxide associated with dextran for
intravenous administration as a magnetic resonance imaging contrast media. Chemically, ferumoxide
is a non-stoichiometric magnetite of average formula FeO1.44. Each milliliter of Feridex I.V.® c tains
11.2 mg of iron. B diluting the origi al Feridex I.V.® solution in purified water, the concentrations of
each tube by weight were 2, 6, 10, 14, 18, and 22 mM. As shown in Figure 2, the tubes were placed in a
cylinder container (10 cm in diameter, 30 cm in height) and filled with agarose gel (0.9% by weight).
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Figure 2. (a) Demonstration of the phantom design. (b) Typical magnitude image of the first echo with
the UTE-Cones sequence at TE = 32 µs.
2.3. Imaging Experiment
The ree different UTE imaging schemes (i.e., UTE-CSPI, UTE-PR, and UTE-Cones) were used to
scan the iron phantom on a 3T clinical MR system (MR750, GE Healthcare, Waukesha, WI, USA) using
a 16-channel receive-only wrap coil (NeoCoil, Pewaukee, WI, USA), with the longitudinal direction of
the tubes placed parallel to the B0 field. The imaging parameters are summarized in Table 1.
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Table 1. Scan parameters of three types of ultrashort echo time (UTE) sequences and the Cones
sequence with four different stretching factors (SFs) of 1.0, 1.2, 1.4, and 1.6.
3D UTE
Sequences
TEs #
(ms)
TR ##
(ms)
Resolution
(mm) Matrix
Scan Time
(mins)
Bandwidth
(kHz)
CSPI 0.528, 0.56, 0.592,0.624, 0.656, 0.688 7 1 × 1 × 1 80 × 80 × 100 10
′56” ±250
PR 0.032, 0.132, 0.232,0.332 7 1 × 1 × 1 140 × 140 × 100 5
′38” × 4 ±83.33
Cones
(SF = 1)
0.032, 0.132, 0.232,
0.332 7 1 × 1 × 1 140 × 140 × 100 2
′36” × 4 ±83.33
Cones
(SF = 1.2)
0.032, 0.132, 0.232,
0.332 7 1 × 1 × 1 140 × 140 × 100 2
′03” × 4 ±83.33
Cones
(SF = 1.4)
0.032, 0.132, 0.232,
0.332 7 1 × 1 × 1 140 × 140 × 100 1
′48” × 4 ±83.33
Cones
(SF = 1.6)
0.032, 0.132, 0.232,
0.332 7 1 × 1 × 1 140 × 140 × 100 1
′32” × 4 ±83.33
# TEs is Echo Times; ## TR is Repetition Time.
For parallel imaging in UTE-CSPI, the following imaging parameters were used: acceleration
factor (AF) = 2 × 2 × 1, matrix size for auto-calibration = 17 × 17 × 100. To further investigate
the effects of readout-gradient stretching, the UTE-Cones imaging was repeated with four different
SFs: 1.0 (default, AF = 2.6 over UTE-PR sampling), 1.2 (AF = 3.5), 1.4 (AF = 4.1), and 1.6 (AF = 5.0).
The stretching factor was defined as the ratio between the sampling window using the stretched spiral
sampling and the sampling window using the PR trajectory, while AF was defined as the ratio of total
scan time of PR sequence to each Cones sequence. The higher SF required a smaller number of spokes
to cover the 3D k-space and, therefore, required a shorter scan time. The other parameters were kept
the same.
2.4. Image Reconstruction
UTE-Cones and UTE-PR images were reconstructed using offline reconstruction codes based
on non-uniform fast Fourier transform (NuFFT) [36]. After the k-space data in each channel were
reconstructed, the images at individual channels were combined to form a complex image [37]. CSPI
images were reconstructed utilizing 3D GRAPPA reconstruction using a kernel size of 5 × 5 × 7
pixels. To enhance signal-to-noise ratio (SNR) in CSPI, consecutive k-spaces within a small TE window
(±16 µs) were temporally averaged after GRAPPA reconstruction as in [28].
2.5. QSM Analysis
Each 3D UTE-Cones acquisition was reconstructed into both magnitude and phase images using
a re-gridding algorithm. Nominal TEs were used for QSM calculation. The MEDI QSM reconstruction
algorithm was applied offline with the same complex matrix for measuring the susceptibility of each
iron phantom [30,38]. For all datasets, the regularization parameter λ and radius for the spherical
mean value operator were kept as 500 and 5, respectively, for calculating magnetic susceptibility χ.
User-defined regions of interest (ROIs) with fixed diameters of 1 cm were used to cover each tube.
All data processing was performed using Matlab 2017b (Mathworks Inc., Natick, MA, USA).
3. Results
3.1. Comparison between UTE Techniques
Figure 3 shows the QSM results of all three UTE imaging techniques (CSPI, PR, and Cones) with
the same scale of susceptibility (ppm). Note that the UTE-CSPI sequence has a smaller sampling
field of view (FOV) than UTE-PR and UTE-Cones sequences, so the iron phantom in Figure 3c
looks bigger than in Figure 3a,b. The resolution was kept the same for all three images. With the
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UTE-Cones (SF = 1.0), the mean and standard deviation of the estimated susceptibility in each tube was
2.0 ± 1.3, 6.6 ± 2.2, 12.3 ± 2.6, 17.3 ± 3.1, 26.6 ± 4.2, and 34.7 ± 9.0 ppm, respectively. The estimated
mean susceptibility showed high linearity (R2 = 0.9817) with the fitted equation for susceptibility,
χCones = 1.6345[Fe] − 3.0292 (ppm). For the UTE-PR sequence, the mean and standard deviation of the
estimated susceptibility in each tube was 1.3 ± 2.1, 6.9 ± 2.0, 12.1 ± 3.1, 18.3 ± 1.4, 25.9 ± 4.6, and
32.0 ± 8.3 ppm, respectively. The estimated mean susceptibility showed high linearity (R2 = 0.9961)
with the fitted equation for susceptibility, χPR = 1.5473[Fe]− 2.5059 (ppm). For the UTE-CSPI sequence,
the mean and standard deviation of the estimated susceptibility in each tube was 2.3 ± 1.3, 8.3 ± 3.1,
14.7 ± 3.6, 21.8 ± 5.0, 26.4 ± 12.4, and 31.1 ± 21.3 ppm, respectively. The estimated mean susceptibility
showed high linearity (R2 = 0.9945) with the fitted equation for susceptibility, χCSPI = 1.4676[Fe] −
0.1852 (ppm).
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Figure 4. Cones-QSM with four different stretching factors of (a) 1.0, (b) 1.2, (c) 1.4, and (d) 1.6,
respectively. The ROI analysis of different iron concentrations is shown in (e). Similar UTE-QSM
values were achieved with different stretching factors, except for the tube with the highest iron
concentration of 22 mM, which showed lower QSM values and greater standard deviations with higher
stretching factors.
For UTE-Cones with an SF of 1.2, the means and standard deviations of the estimated susceptibility
in each tube were 1.8± 1.2, 6.4± 2.0, 12.1± 2.1, 17.5± 3.3, 27.1± 4.7, and 33.7± 11.0 ppm, respectively.
For UTE-Cones with an SF of 1.4, the means and standard deviations of the estimated susceptibility in
each tube were 1.9 ± 1.4, 6.3 ± 2.1, 12.1 ± 2.3, 17.1 ± 3.3, 27.2 ± 4.6, and 33.4 ± 12.1 ppm, respectively.
For UTE-Cones with an SF of 1.6, the means and standard deviations of the estimated susceptibility in
each tube were 1.0 ± 1.4, 6.4 ± 2.1, 12.4 ± 2.3, 17.3 ± 3.3, 27.0 ± 5.6, and 34.7 ± 11.6 ppm, respectively.
As can be seen, QSM estimates of different SFs showed very consistent results for most of the tubes
between UTE-Cones with different SFs, except for the 22 mM tube, where slightly higher QSM values
were shown with SFs of 1.0 and 1.6 than with the other two SFs.
4. Discussion
The performance of QSM combined with various UTE imaging techniques was investigated for
fast and accurate evaluation of highly concentrated MNPs. The relatively long scan time in UTE-QSM
is a significant barrier for widespread clinical adoption. Accelerated UTE-QSM may facilitat future
clinical stud es associated with high iron concent ations, such as magnetic hyperthermia therapy,
hemophilia, etc. In this study, we compa d the perform nce of different UTE-QSM techniques based
on 3D PR, CSPI, and Cones with different stretching f ctors nging from 1.0 to 1.6. The phantom
studies suggested that the Cone sequence had similar accuracy to PR and CSPI sequences in the
UTE-QSM assessment of MNPs concentration. Furthermore, a higher stretching factor of up to 1.6,
which corresponds to an acceleration factor of 5, did not significantly affect the QSM estimation.
To the best of our knowledge, this is the first study comparing different UTE sampling strategies
for the UTE-QSM assessment of high MNPs concentrations. The fact that Cones-QSM with a high
stretching factor allows fast and accurate estimation of highly concentrated MNPs is of significant
clinical importance, and may play a role in advancing the translational study of iron mapping.
The CSPI sequence is believed to provide the most accurate phase information, owing to its
near-zero readout duration [16]. However, the scan time imposed by 3D phase encoding is a crucial
issue for clinical applications. The 3D Cones sequence is based on center-out spiral readout trajectories,
where the k-space data are encoded on the surface of multiple cones, allowing more efficient encoding
than other UTE imaging techniques. When using similar imaging parameters, as shown in Table 1,
the Cones sequence required a shorter scan time than both CSPI and PR sequences. The phantom
experiments show that the estimated QSM values were almost the same with three different UTE
imaging techniques. This indicates that the Cones sequence allowed accurate evaluation of MNPs
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concentrations from 2 to 22 mM within a much shorter scan time, which is beneficial for clinical
applications. The concentration range covered the therapeutic range threshold of 18 mM. Higher
concentrations of MNPs could also be evaluated with UTE-Cones with shorter echo spacing time,
according to our previous study [27].
Another advantage of UTE-Cones imaging is that each spiral arm can be stretched on the conical
surface to more efficiently cover the surface of each cone in 3D k-space. Therefore, a much-reduced
number of spiral arms (or readouts) is required to cover one cone, which can further reduce the total
scan time. Moreover, the stretched spiral arms in UTE-Cones allow a more uniform sampling density,
which may improve SNR efficiency [36,39]. In our study, as seen in Table 1, changing SF from 1 to
1.6 reduced the scan time from 156 s to 92 s. However, a higher SF will introduce increased short T2*
blurriness and chemical shift artifacts due to a longer readout duration. Moreover, the effective TE will
deviate more from the prescribed TE with a higher SF due to the stretched readout. In the iron phantom
experiment, an SF of up to 1.6 did not significantly affect QSM results for the tubes with concentrations
from 2 to 18 mM. For the tube with the highest iron concentration of 22 mM, the estimated susceptibility
appeared slightly changed with the increased SFs. The instability is presumably caused by increased
short T2* blurring, the increased deviation in effective TEs from the prescribed TEs, and increased
off-resonance artifacts. Because of these factors, we did not test SF higher than 1.6, which works for
low iron concentrations but fails for high iron concentrations.
In this study, the quantitative evaluation of MNPs concentration was based on MRI methodology.
Besides MRI, there are many other methodologies that have the ability to detect highly concentrated
MNPs, such as magnetic particle imaging (MPI), ultrasound (US), magnetoimpedance, inductive
technique, etc. MPI is based on the non-linear magnetization response of the super-magnetic property
of the MNPs, and is a promising way to obtain the distribution of MNPs. However, state-of-the-art
MPI has limited resolution (~500 µm) and small FOV (<100 mm × 100mm) due to the requirement
of a high gradient field, which is not yet applicable for in vivo human studies [40,41]. US is one of
the most used biomedical imaging techniques in clinical practice. Recent reports suggest that the
signal of magneto-motive ultrasound (MMUS) is proportional to the concentration of the MNPs.
However, US has limitations in its resolution, contrast, and penetration depth [42]. Magnetic field
detection methods with magnetic induction sensors, such as superconducting quantum interference
device (SQUID)-based sensors, giant magneto-impedance (GMI) sensors, and giant magneto-resistance
(GMR) sensors, etc., have very high sensitivity (as high as 10−10 Oe) for detecting ferromagnetic
biomaterials [43,44]. However, these methods are mainly used for detection of a signal from a local
area and are not yet applicable for imaging.
There are several limitations of this study. First, the highest concentration of MNPs in this
study was 22 mM, which is lower than the 37.5 mM concentration used in a study of UTE T2* or T1
measurement [25], and the 57.5 mM concentration used in a study of SWIFT [17]. Second, MNPs of
different concentrations were suspended homogeneously in our phantom; however, MNPs would be
expected to accumulate or aggregate within biological tissues, causing nonhomogeneous susceptibility
values in vivo. Third, our study is limited by the absence of in vivo results. However, there are
currently no clinical MRI techniques available for the quantitative imaging of highly concentrated
MNPs. It is crucial that we first develop novel UTE-QSM techniques for the evaluation of highly
concentrated MNPs, such as the Feridex solutions included in this study. Synthetic polymer gels and
natural biopolymers, which better mimic biological tissues, will be used for future studies before
translating the developed techniques for in vivo imaging [45,46]. Fourth, the chemical shift effect was
not considered in this study. UTE-QSM together with the iterative decomposition of water and fat with
echo asymmetry and least squares estimation (IDEAL) techniques may help resolve potential issues.
As this study focused on the measurable MNPs concentrations with various UTE-QSM sequences, it
was unlikely that the chemical shift effect influenced the results of our phantom studies. Fifth, only
MEDI-based QSM processing was considered in this study. UTE acquisitions combined with other
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QSM processing algorithms, such as improved sparse linear equation and least-squares (iLSQR), will
be investigated in future studies [47].
5. Conclusions
In this study we investigated the feasibility of quantitative susceptibility mapping combined with
various ultrashort echo time sequences for the fast and accurate estimation of highly concentrated
MNPs. Different UTE sampling strategies, including 3D PR, CSPI, and Cones with four different
stretching factors were compared, and the results showed no significant difference in QSM values for
MNPs up to 22 mM. The Cones-QSM sequence with a stretching factor up to 1.6 can be used for the
fast and accurate mapping of high iron concentrations.
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